James Alderman
Cardiovascular Disease · Framingham, MANPI 1457342065
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Johnson & Johnson at 24.0% of the total.
Across 111 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$577
- Amgen$219
- E.r. Squibb & Sons, L.L.C.$217
- AstraZeneca$208
- Novartis$173
- Esperion Therapeutics, Inc.$125
- plus $884 from 16 others
What the payments were for
- Food & beverage$2,36899%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $577 |
| Amgen | 8 | $219 |
| E.r. Squibb & Sons, L.L.C. | 9 | $217 |
| AstraZeneca | 13 | $208 |
| Novartis | 10 | $173 |
| Esperion Therapeutics, Inc. | 5 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Alnylam Pharmaceuticals Inc. | 4 | $109 |
| Pfizer | 5 | $93 |
| Biotronik Inc. | 3 | $75 |
| Merck | 4 | $74 |
| Amarin Pharma, Inc. | 4 | $72 |
| Medtronic | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 5 | $54 |
| Novo Nordisk | 2 | $47 |
| Boehringer Ingelheim | 2 | $43 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Philips North America LLC | 1 | $22 |
| Bayer | 1 | $18 |
| Chiesi USA, Inc. | 1 | $11 |
| Terumo Medical Corporation | 1 | $11 |
How this compares
$2,403 in reported general payments places this provider in the 60th percentile of 750 cardiovascular disease providers in Massachusetts.
Other cardiovascular disease in Framingham
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- Kevin CroceChestnut Hill$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.